These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


456 related items for PubMed ID: 15969661

  • 21. The effect of montelukast versus usual care on health care resource utilization in children aged 2 to 5 years with asthma.
    Davies GM, Dasbach EJ, Santanello NC, Knorr BA, Bratton DL.
    Clin Ther; 2004 Nov; 26(11):1895-904. PubMed ID: 15639701
    [Abstract] [Full Text] [Related]

  • 22. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.
    Sorkness CA, Lemanske RF, Mauger DT, Boehmer SJ, Chinchilli VM, Martinez FD, Strunk RC, Szefler SJ, Zeiger RS, Bacharier LB, Bloomberg GR, Covar RA, Guilbert TW, Heldt G, Larsen G, Mellon MH, Morgan WJ, Moss MH, Spahn JD, Taussig LM, Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute.
    J Allergy Clin Immunol; 2007 Jan; 119(1):64-72. PubMed ID: 17140647
    [Abstract] [Full Text] [Related]

  • 23. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM, Akazawa M, Dalal A, Simoni-Wastila L.
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [Abstract] [Full Text] [Related]

  • 24. Adherence to asthma controller medication regimens.
    Stempel DA, Stoloff SW, Carranza Rosenzweig JR, Stanford RH, Ryskina KL, Legorreta AP.
    Respir Med; 2005 Oct; 99(10):1263-7. PubMed ID: 16140227
    [Abstract] [Full Text] [Related]

  • 25. Obtaining concomitant control of allergic rhinitis and asthma with a nasally inhaled corticosteroid.
    Camargos P, Ibiapina C, Lasmar L, Cruz AA.
    Allergy; 2007 Mar; 62(3):310-6. PubMed ID: 17298349
    [Abstract] [Full Text] [Related]

  • 26. Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy.
    Johnston NW, Mandhane PJ, Dai J, Duncan JM, Greene JM, Lambert K, Sears MR.
    Pediatrics; 2007 Sep; 120(3):e702-12. PubMed ID: 17766511
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

  • 30. Pretreatment with albuterol versus montelukast for exercise-induced bronchospasm in children.
    Raissy HH, Harkins M, Kelly F, Kelly HW.
    Pharmacotherapy; 2008 Mar; 28(3):287-94. PubMed ID: 18294107
    [Abstract] [Full Text] [Related]

  • 31. Predictors of asthma control in everyday clinical practice in Switzerland.
    Taegtmeyer AB, Steurer-Stey C, Price DB, Wildhaber JH, Spertini F, Leuppi JD.
    Curr Med Res Opin; 2009 Oct; 25(10):2549-55. PubMed ID: 19735165
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma.
    Dahl R, Chuchalin A, Gor D, Yoxall S, Sharma R.
    Respir Med; 2006 Jul; 100(7):1152-62. PubMed ID: 16675212
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Outcomes of patients treated with fluticasone propionate or montelukast sodium.
    Allen-Ramey FC, Duong PT, Goodman DC, Sajjan SG, Nelsen LM, Markson L.
    Manag Care Interface; 2003 Aug; 16(8):30-5. PubMed ID: 12964550
    [Abstract] [Full Text] [Related]

  • 38. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
    Virchow JC, Bachert C.
    Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Adding salmeterol to an inhaled corticosteroid reduces allergen-induced serum IL-5 and peripheral blood eosinophils.
    Koopmans JG, Lutter R, Jansen HM, van der Zee JS.
    J Allergy Clin Immunol; 2005 Nov; 116(5):1007-13. PubMed ID: 16275368
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 23.